Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: Clinical Study Aimed At Evaluating the Safety and Efficacy of Tear Substitute Formulations in the Treatment of Dry Eye Disease. [EARLY_Phase 1]

View source ↗

Summary

This early-phase Phase 1 trial evaluates the safety and efficacy of tear substitute formulations for Dry Eye Disease, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tear substitute formulations

Snippet

Sponsor: PS Therapy Inc. | Conditions: Dry Eye Disease (DED) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING